What is Aphakia Market?
Aphakia is the nonappearance of the lens of the eye, due to surgical removal, a perforating wound or ulcer, or congenital anomaly. It causes a loss of accommodation, farsightedness (hyperopia), and a deep anterior chamber. Complications such as the detachment of the vitreous or retina and glaucoma. This condition is most common in adults with cataracts, but it can also affect infants and children. Aphakia is a condition in which there is an absence or dislocation of the crystalline eye lens from its normal position of the pupillary area. It occurs due to the presence of diseases such as congenital or trauma conditions or after surgery for cataract removal. This condition is most common in adults with cataracts. However, this condition can also affect infants and children.
The market study is being classified by Type (Primary and Secondary) and major geographies with country level break-up.
Johnson&JohnsonServices,Inc. (United States), OphtecBV (Netherland), Novartis (Switzerland), Rayner(United Kingdom), Bohus BioTech AB (Sweden), Lifecore Biomedical (United States), Aetna Inc. (United States), The Cooper Companies Inc. (United States), Menicon (Japan) and Labtician Ophthalmics, Inc. (Canada) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Contact Fill (United States).
The global Aphakia market is fragmented by numerous key players The intensity of rivalry appears to be high in this market as competitors are numerous and the products are undifferentiated. Major companies in this market are constantly working towards introducing innovative products and lowering production costs in order to enhance profitability. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Aphakia market throughout the predicted period.
Analyst at AMA have segmented the market study of Global Aphakia market by Type, Application and Region.
On the basis of geography, the market of Aphakia has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Growing demand for treatment of the ophthalmic disease
- Increased geriatric population
- Restrictive field of vision
- Lack of a number of professionals
- Rapid development in the healthcare sector and rising geriatric population and technological advancement in the healthcare sector fuel
- Poor cosmetic appearance
- Less treatment availability
In February 2019 Johnson & Johnson Vision Announces the launch of its TECNIS Eyhance IOL to treat cataracts in Europe. The TECNIS Eyhance IOL, model ICB00, is pointed to for the visual correction of aphakia in adult patients in whom a cataractous lens has been removed by extracapsular cataract extraction.
Key Target AudienceNew Entrants/Investors, Analysts and Strategic Business Planners, Aphakia Providers, Venture Capitalists and Private Equity Firms, Government Regulatory and Research Organizations and End-Use Industry
Customization in the Report Available:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase